WO1999053037A2 - Sequences optimisees de nucleosides codant pour des hydrolases organophosphorees, et leurs methodes d'utilisation - Google Patents

Sequences optimisees de nucleosides codant pour des hydrolases organophosphorees, et leurs methodes d'utilisation Download PDF

Info

Publication number
WO1999053037A2
WO1999053037A2 PCT/US1999/008202 US9908202W WO9953037A2 WO 1999053037 A2 WO1999053037 A2 WO 1999053037A2 US 9908202 W US9908202 W US 9908202W WO 9953037 A2 WO9953037 A2 WO 9953037A2
Authority
WO
WIPO (PCT)
Prior art keywords
plant
sequence
expression
nucleotide sequence
gene
Prior art date
Application number
PCT/US1999/008202
Other languages
English (en)
Other versions
WO1999053037A3 (fr
Inventor
Joseph M. Jilka
Original Assignee
Prodigene, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prodigene, Inc. filed Critical Prodigene, Inc.
Priority to AU40689/99A priority Critical patent/AU4068999A/en
Publication of WO1999053037A2 publication Critical patent/WO1999053037A2/fr
Publication of WO1999053037A3 publication Critical patent/WO1999053037A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8274Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for herbicide resistance
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)

Definitions

  • Synthetic organophosphorous neurotoxins are used extensively as agricultural and domestic pesticides, including insecticides, fungicides, and herbicides.
  • Naturally occurring bacterial isolates capable of metabolizing this class of compounds have received considerable attention since they provide the possibility of both environmental and in situ detoxification.
  • Pseudomonas putida MG, Pseudomonas diminuta, and Fla ⁇ obacterium, s.pp. have been shown to possess the ability to degrade an extremely broad spectrum of organophosphorous phosphotriesters as well as thiol esters.
  • Organophosphorous hydrolase is a broad spectrum OP hydrolase that is capable of detoxifying organophosphorous neurotoxins by creating various phosphoryl bonds (P-O, P-F, P-CN, and P-S) between the phosphorous center and varying electrophilic leaving groups.
  • This enzyme is often identified by more limited descriptors such as phosphotriesterase, DFPase, parathion hydrolase, parathion aryl esterase, or paraoxonase as well as being called a somanase or sarinase.
  • the hydrolytic reaction rates with several phosphotriesterases appears to be limited by diffusion to the active center of the enzyme. (Caldwell et al., "Limits of Diffusion in the Hydrolysis of Substrates of the Phosphotriesterase From Pseudomonas diminuta 1 ', Biochemistry 30, 7438-7444 (1991)).
  • This broad spectrum hydrolase is the only enzyme which has been shown to be able to hydrolyze the P-S bond of various phosphorothioate pesticides.
  • the toxicity of hydrolyzed products has been shown to be significantly reduced as indicated by the loss of inhibition of acetyl cholinesterase activity and by decreased neurotoxic response in animals. (Kolakowski, et al., Biocatolisis and Biotransformation, Vol. 15, 297-312 (1997)).
  • OP-thioate insecticides acephate, azinophos-ethyl, demeton-S, malathion and phosalone have been shown to be hydrolyzed by OPH.
  • the hydrolysis of these pesticides has a first order dependency on the amount of enzyme used and the reaction time.
  • the enzyme hydrolyzed acephate, azinophos-ethyl, demeton-S and phosalone at relatively fast velocities with reaction rates which are thousands of times greater than that which occurs during strong alkaline hydrolysis.
  • the enzyme possessed poor capability for a malathion hydrolysis, although still significantly better than non-enzymatic hydrolysis under similar conditions.
  • the thioesters (P-S bond esters) hydrolysis was much slower in general. (See Kolakowski, et al., Biokatolisis and Biotransformation, Vol., 297-312 (1997)).
  • the present invention relates to the plant expression of OPH as well as the creation of a synthetic OPH nucleotide sequence which can be expressed in plant systems or yeast systems utilizing appropriate leader sequences whereby the expression level of OPH is greatly increased over that of E. coli or baculovirus systems.
  • the present invention relates not only to the creation of the optimized OPH coding sequence, but also to transformation, expression of the same, and useof the recombinant protein in the hydrolysis of a variety of organophosphorous neurotoxins such as those in many widely used agricultural and domestic pesticides.
  • the present invention is directed to a nucleotide sequence which encodes OPH and its expression in plant systems.
  • the present invention is directed to a nucleotide sequence which encodes an optimized OPH gene preferrably with a host specific leader sequence.
  • the present invention is further directed to expression constructs, vectors and transgenic plants which contain these OPH nucleotide sequences.
  • the invention is directed to the expression of OPH in plant or yeast cells.
  • the present invention is also directed to methods for using transgenic plants which express this OPH to detoxify environments which are contaminated with insecticides and other neurotoxins. More specifically, the present invention is directed to transgenic plants which are capable of expressing OPH at levels greater than that of the typical 10-15 mg/1 of E. coli or baculovirus.
  • OPH nucleotide sequence of the present invention can be utilized in conjunction with a wide variety of host organisms including plants, bacteria and yeast. It should also be understood that trivial modifications to the OPH gene of this invention are encompassed in this invention. Further, while it is to be understood that the expression of the OPH of the present invention can be utilized either as present in the transgenic plants or harvested therefrom to hydrolyze neurotoxins such as pesticides, this expressed OPH gene can further be utilized to hydrolyze other chemical agents or compounds containing P-O, P-S, P-CN, and P-S bonds. BRIEF DESCRIPTION OF THE FIGURES
  • Fig. 1 is a schematic of optimized OPH nucleotide sequence showing the restriction sites used in the synthesis of the gene.
  • Fig. 2 is an optimized nucleotide sequence encoding OPH gene (SEQ ID NO:3).
  • Fig. 3A and 3B are a nucleotide sequence which encodes plant leader sequence (SEQ ID NO:7).
  • Fig. 4A and 4B are a nucleotide sequence which encodes OPH and which also contains a plant leader sequence (SEQ ID NO:5).
  • the present invention includes novel nucleotide sequences which are optimized to encode an organophosphorous hydrolase protein.
  • An expression construct comprising this sequence and regulatory elements for OPH expression in a host organism is also provided.
  • the present invention also includes plants, seeds, and plant tissue capable of expressing the novel nucleotide sequence.
  • Coding DNA Sequence A DNA sequence from which the information for making a peptide molecule, mRNA, or tRNA are transcribed.
  • a DNA sequence may be a gene, combination of genes, or a gene fragment.
  • Gene A chromosomal region which is responsible for a cellular product.
  • Microorganism A member of one of the following classes; bacteria, fungi, protozoa or viruses.
  • Plant Tissue Any tissue of a plant in plant or in culture. This term includes, but is not limited to, whole plants, plant cells, plant organs, plant seeds, embryos, pollen, silk, tassel, leaf, root, protoplasts, callus, cell cultures and any other group of plant cells organized into structural and/or functional units. The use of this term in conjunction with, or in the absence of, any specific type of plant tissue as listed above or otherwise embraced by this definition is not intended to be exclusive of any other type of plant tissue.
  • Plant Transformation Vector A plant, bacterial or viral vector that is capable of transforming plant tissue such that following transformation the plant tissue contains the DNA to be introduced by the vector in the plant tissues.
  • Substantial Sequence Homology Substantial functional and/or structural equivalents between sequences of nucleotides or amino acids. Functional and/or Structural Differences between sequences having substantial sequence homology will be diminimous.
  • Synthetic Gene A DNA sequence that exists in total or in part through manufacture by manufacture in vitro.
  • Transgenic Plant a plant which contains and expresses DNA that was not pre-existing in the plant, either at all or in the post-transformation quantity, prior to the introduction of the DNA into the plant.
  • Organophosphorous hydrolase protein as used herein this term shall mean any protein or protein fragment which maintains the functional properties of OPH as determined by the assays described in Daie et al., "Characterization of Organophosphorous Hydrolases and the Genetic Manipulation of the Phosphotriesterase from Pseudomonas diminuta", Chemical-Biological Interactions, 87, 55-68 (1993), and Caldwell et al., "Limits of Diffusion in the Hydrolysis of Substrates of the Phosphotriesterase From Pseudomonas diminuta", Biochemistry 30, 7438-7444 (1991).
  • this will be an amino acid with at least 30%-50% homology with at least one form of the protein as disclosed herein. 80% homology is preferred and 90% homology is most preferred especially including conservative substitutions.
  • Homology is calculated by standard methods which involve aligning two sequences to be compared so that the maximum matching occurs, and calculating the percentage of matches. Substantially equivalent substances to these include those wherein one or more of the residues of the native sequence is deleted, substituted for, or inserted by a different amino acid or acids.
  • Preferred substitutions are those which are conservative, i.e., wherein a residue is replaced by another of the same general type.
  • naturally occurring amino acids can be sub classified as acidic, basic, neutral and polar, or neutral and nonpolar.
  • peptides differing from the native OPH sequence contain substitutions which are from the same group as that of the amio acid replaced.
  • the basic amino acids Lys and Arg are interchangeable; the acidic amino acids aspartic and glutamic are interchangeable; the neutral polar amino acids Ser, Thr, Cys, Gin, and Asn are interchangeable; the nonpolar aliphatic acids Gly, Ala, Val, lie, and Leu are conservative with respect to each other (but because of size, Gly and Ala are more closely related and Val, lie and Leu are more closely related), and the aromatic amino acids Phe, Trp, and Tyr are interchangeable.
  • proline is a non-olar neutral amino acid, it represents difficulties because of its effects on conformation, and substitutions by or for proline are not preferred, except when the same or similar conformational results can be obtained.
  • Polar amino acids which represent conservative changes include Ser, Thr, Gin, Asn; and to a lesser extent, Met.
  • Ala, Gly, and Ser seem to be interchangeable, and Cys additionally fits into this group, or may be classified with the polar neutral amino acids. In general, whatever substitutions are made are such that the functional properties of the intact proteinaceous molecule is retained and ancillary properties, such as non-toxicity are not substantially disturbed as described earlier.
  • conditions of high stringency shall mean nucleotide hybridization conditions equivalent to the following: 42°C in a buffer containing 50% formamide, 1M sodium chloride, 1% SDS, 10% dextran sulfate, 100 ⁇ g/ml denatured salmon sperm, or those described in Reppert, S.M. et al. (1994) Neuron 13:1177-1185. Optimized OPH Gene
  • Codons were chosen so that deleterious mRNA signals would be eliminated in the DNA coding sequence.
  • convenient restriction enzyme cites were added to facilitate downstream cloning.
  • the optimized DNA coding sequence was divided into convenient cloning lengths and then each of these lengths were further subdivided into oligonucleotide s of approximately 50 bases in length with 10 base overhangs. Oligonucleotides corresponding to both the sense and antisense strand were synthesized and 5' phosphorylated. The oligonucleotides were then annealed and ligated. Following ligation, varying dilutions were subjected to PCR using primers specific to the 5' and 3' ends.
  • PCR product was analyzed using poly acrylamide gels, and DNA of the proper expected lengths was extracted from the gel and the DNA eluted from the extracted gel material.
  • the DNA was cloned into a pCR 2.1 TOPO(Invitrogen) plasmid as per the manufacturer's instructions. Transformed colonies containing the PCR insert were grown overnight and the plasmid DNA purified. The plasmid DNA was then analyzed for the correct PCR insert as per standard protocols known to those of skill in the art. The inserts were sequenced to verify that the correct sequence was created and the optimized gene was assembled properly using standard protocols known to those of skill in the art. Appropriate Leader Sequence
  • an appropriate leader sequence or subcellular localization signal is preferably integrated onto the OPH encoding nucleotide sequence gene.
  • a plant leader sequence will ensure high expression in plants while a yeast leader sequence will express high levels of OPH expression in yeast.
  • the OPH gene containing the appropriate leader can be cloned into the standard expression cassette for that host to ensure high expression in that organism.
  • a 5' fragment can be assembled to contain a plant leader sequence to ensure high expression in plants.
  • the OPH gene containing the plant leader may be cloned into a standard plant upon expression cassette to ensure high expression in plants. Transformation techniques
  • a nucleotide acid sequence of interest is isolated or synthesized, it is included into an expression cassette which typically comprises a transcription unit of a promoter operably linked to the nucleotide sequence which is functional in a plant cell and a termination or polyadenylation signal.
  • This expression cassette typically forms part of a plant transformation vector.
  • This plant transformation vector will also contain the appropriate regulatory sequences in addition to the gene of interest.
  • the vector DNA facilitates manipulation of the gene in the host cell, such as E. coli. or yeast, prior to plant transformation.
  • the host vector-cell can act as a vehicle to transfer the gene to the host plant such as the case of the plant pathogenic bacterium, Agrobacterium tumefaciens.
  • An idealized vector would contain a multiple cloning site, an antibiotic resistance or other selective gene, a broad- host bacterial origin of replication, and a selection marker or gene for selection of the foreign DNA in transformed plants.
  • constructs, promoters or control systems used in the methods of the invention may include a tissue specific promoter, an inducible promoter or a constitutive promoter.
  • CaMV cauliflower mosaic virus 35S. It has been shown to be highly active in many plant organs and during many stages of development when integrated into the genome of transgenic plants including tobacco and petunia, and has been shown to confer expression in protoplasts of both dicots and monocots.
  • Organ-specific promoters are also well known.
  • the E8 promoter is only transcriptionally activated during tomato fruit ripening, and can be used to target gene expression in ripening tomato fruit (Deikman and Fischer, EMBO J. (1988) 7:3315; Giovannoni et al., The Plant Cell (1989) 1:53).
  • the activity of the E8 promoter is not limited to tomato fruit, but is thought to be compatible with any system wherein ethylene activates biological processes.
  • the Lipoxegenase (“the LOX gene") is a fruit specific promoter.
  • Seed specific promoters include the Napin promoter described in united States Patent 5,110,728 to Calgene, which describes and discloses the use of the napin promoter in directing the expression to seed tissue of an acyl carrier protein to enhance seed oil production; the DC3 promoter from carrots which is early to mid embryo specific and is disclosed at Plant Physiology, Oct. 1992 100(2) p. 576-581, "Hormonal and Environmental Regulation of the Carrot Lea-class Gene Dc 3, and Plant Mol. Biol., April 1992, 18(6) p.
  • phaseolin promoter described in United States Patent 5,504,200 to Mycogen which discloses the gene sequence and regulatory regions for phaseolin, a protein isolated from P. vulgaris which is expressed only while the seed is developing within the pod, and only in tissues involved in seed generation.
  • organ-specific promoters appropriate for a desired target organ can be isolated using known procedures. These control sequences are generally associated with genes uniquely expressed in the desired organ. In a typical higher plant, each organ has thousands of mRNAs that are absent from other organ systems (reviewed in Goldberg, Phil, Trans. R. Soc. London (1986) B314-343. mRNAs are first isolated to obtain suitable probes for retrieval of the appropriate genomic sequence which retains the presence of the natively associated control sequences. An example of the use of techniques to obtain the cDNA associated with mRNA specific to avocado fruit is found in Christoffersen et al., Plant Molecular Biology (1984) 3:385. Briefly, mRNA was isolated from ripening avocado fruit and used to make a cDNA library.
  • Clones in the library were identified that hybridized with labeled RNA isolated from ripening avocado fruit, but that did not hybridize with labeled RNAs isolated from unripe avocado fruit. Many of these clones represent mRNAs encoded by genes that are transcriptionally activated at the onset of avocado fruit ripening.
  • the promoter used in the method of the invention may also be an inducible promoter.
  • An inducible promoter is a promoter that is capable of directly or indirectly activating transcription of a DNA sequence in response to an inducer. In the absence of an inducer, the DNA sequence will not be transcribed.
  • the protein factor that binds specifically to an inducible promoter to activate transcription is present in an inactive form which is then directly or indirectly converted to the active form by the inducer.
  • the inducer may be a chemical agent such as a protein, metabolite (sugar, alcohol etc.), a growth regulator, herbicide, or a phenolic compound or a physiological stress imposed directly by heat, salt, toxic elements etc.
  • a plant cell containing an inducible promoter may be exposed to an inducer by externally applying the inducer to the cell such as by spraying, watering, heating, or similar methods.
  • inducible promoters include the inducible 70 kd heat shock promoter of D. melanogaster (Freeling, M., Bennet, D.C., Maize ADN 1, Ann. Rev, of Genetics, 19:297-323) and the alcohol dehydrogenase promoter which is induced by ethanol (Nagao, R.T., et al., Miflin, B.J., Ed. Oxford Surveys of Plant Molecular and Cell Biology, Vol. 3, p.
  • the inducible promoter may be in an induced state throughout seed formation or at least for a period which corresponds to the transcription of the DNA sequence of the recombinant DNA molecule(s).
  • Another example of an inducible promoter is the chemically inducible gene promoter sequence isolated from a 27 kd subunit of the maize glutathione-S-transferase (GST II) gene.
  • a number of other potential inducers may be used with this promoter as described in published PCT Application No. PCT/GB90/00110 by ICI.
  • inducible promoter is the light inducible chlorophyll a/b binding protein (CAB) promoter, also described in published PCT Application No. PCT/GB90/00110 by ICI.
  • CAB chlorophyll a/b binding protein
  • inducible promoters have also been described in published Application No. EP89/103888.7 by Ciba-Geigy.
  • PR protein genes especially the tobacco PR protein genes, such as PR-la, PR- lb, PR-lc, PR-1, PR-A, PR-S, the cucumber chitinase gene, and the acidic and basic tobacco beta-l,3-glucanase genes.
  • inducers for these promoters as described in Application No. EP89/103888.7.
  • the preferred promoters may be used in conjunction with naturally occurring flanking coding or transcribed sequences of the seed specific Polycomb genes or with any other coding or transcribed sequence that is critical to Polycomb formation and/or function.
  • intron sequences may also be desirable to include some intron sequences in the promoter constructs since the inclusion of intron sequences in the coding region may result in enhanced expression and specificity.
  • regions of one promoter may be joined to regions from a different promoter in order to obtain the desired promoter activity resulting in a chimeric promoter.
  • Synthetic promoters which regulate gene expression may also be used.
  • the expression system may be further optimized by employing supplemental elements such as transcription terminators and/or enhancer elements.
  • an expression cassette or construct should also contain a transcription termination region downstream of the structural gene to provide for efficient termination.
  • the termination region or polyadenylation signal may be obtained from the same gene as the promoter sequence or may be obtained from different genes.
  • Polyadenylation sequences include, but are not limited to the Agrobacterium octopine synthase signal (Gielen et al., EMBO J. (1984) 3:835-846) or the nopaline synthase signal (Depicker et al., Mol. and Appl. Genet. (1982) 1:561-573). MARKER GENES
  • Recombinant DNA molecules containing any of the DNA sequences and promoters described herein may additionally contain selection marker genes which encode a selection gene product which confer on a plant cell resistance to a chemical agent or physiological stress, or confers a distinguishable phenotypic characteristic to the cells such that plant cells transformed with the recombinant DNA molecule may be easily selected using a selective agent.
  • selection marker gene is neomycin phosphotransferase (NPT II) which confers resistance to kanamycin and the antibiotic G-418.
  • Cells transformed with this selection marker gene may be selected for by assaying for the presence in vitro of phosphorylation of kanamycin using techniques described in the literature or by testing for the presence of the mRNA coding for the NPT II gene by Northern blot analysis in RNA from the tissue of the transformed plant. Polymerase chain reactions are also used to identify the presence of a transgene or expression using reverse transcriptase PCR amplification to monitor expression and PCR on genomic DNA. Other commonly used selection markers include the ampicillin resistance gene, the tetracycline resistance and the hygromycin resistance gene. Transformed plant cells thus selected can be induced to differentiate into plant structures which will eventually yield whole plants. It is to be understood that a selection marker gene may also be native to a plant. TRANSFORMATION
  • Agrobacterium tumefaciens is the etiologic agent of crown gall.
  • the wild type form of Agrobacterium tumefaciens carries the Ti (tumor-inducing) plasmid that directs the production of tumorigenic crown gall growth on the host plants.
  • the crown gall is produced following the transfer of the tumor inducing T-DNA region from the Ti plasmid into the genome of an infected plant. This DNA fragment encodes genes for auxin and cytokinin biosynthesis, and it is these hormones in high concentration that promote growth of undifferentiated cells in the crown gall.
  • Transfer of the T-DNA to the plant genome requires that the Ti plasmid-encoded virulence genes as well as the T- DNA borders, a set of direct DNA repeats that delineate the region to be transferred.
  • the tumor inducing genes can be removed from Ti plasmid vectors, disarming the pathogenic nature of the system, without affecting the transfer of DNA fragments between the T-DNA borders. Therefore, the tumor inducing genes are generally replaced with a gene encoding resistance to kanamycin, or some other gene, to allow for selection of transformants, and a gene encoding the desired trait.
  • the Agrobacterium containing the engineered plasmid is co-cultivated with cultured plant cells or wounded tissue. The de- differentiated plant cells are then propagated on selective media, and a transgenic plant is subsequently regenerated from the transformed cells by altering the levels of auxin and cytokinin in the growth medium.
  • Agrobacterium mediated transformation often employ binary vector systems, which divide the Ti plasmid into two components, a shuttle vector and a helper plasmid.
  • the helper plasmid which is permanently placed in the Agrobacterium host, carries the virulence genes.
  • a much smaller shuttle vector contains T-DNA borders, a broad-host range bacterial origin of replication, antibiotic resistance markers, and a multiple cloning site for incorporation of the foreign gene.
  • a similar strategy employs cointegrating Ti plasmid vectors, whereby an intermediate plasmid containing antibiotic resistance, the gene to be transferred and one T-DNA border are used to transform A.
  • tumefaciens containing a disarmed Ti plasmid possessing the virulence genes and one T- DNA border.
  • the two plasmids homologously recombined in vivo at the T- DNA borders placing the antibiotic resistance gene and the gene of interest between two T-DNA borders, one from each plasmid.
  • the genes are then transferred into plant tissue upon co-cultivation.
  • the Agrobacterium system has been well studied and has further been developed into a system which permits routine transformation of a variety of plant tissues.
  • Some of the tissues transformed utilizing Agrobacterium include tobacco, Barton, K.A. et al., Cell, 32:1033 (1983); tomato, Fillatti, J. et al., Bio/Technology, 5:726 (1987); sunflower, Everett, N. P. et al., Bio/Technology, 5:1201 (1987); cotton, Umbeck, P.
  • Agrobacterium rhizogenes Another vector for biological plant transformation is Agrobacterium rhizogenes.
  • A. rhizogenes which incite root formation in many dicotyledonous plant species, carries the Ri (root-inducing) plasmid which functions in a manner analogous to the Ti plasmid of A. tumefaciens. Transformation using A. rhizogenes has also been successfully utilized to transform plants, for example, alfalfa, Sukhapinda, K. et al, Plant Mol. Biol.. 8:209 (1987); Solanum nigrum L., Wei Z-H. et al., Plant Cell Reports 5:93 (1986); and, poplar, Pythoud, et al., supra.
  • Electroporation is another effective means of introducing foreign DNA into plant cells.
  • This technique involves transferring naked DNA into cells utilizing electrophoretic means. Since any DNA fragment can be delivered to the cell, this technique has the advantage of allowing assimilation of a gene without having to clone the DNA into a host vector such as A. tumefaciens.
  • DNA viruses have been used as gene vectors. Both Cauliflower Mosaic Virus (CaMV) and the closely related Figwort Virus are circular duplex DNA viruses which replicate via transcription of a full-length (35S) genomic RNA intermediate. A cauliflower mosaic virus carrying a modified bacterial methotrexate-resistance gene was used to infect a plant, whereby the foreign gene was systemically spread in the plant.
  • CaMV Cauliflower Mosaic Virus
  • Figwort Virus DNA viruses
  • a cauliflower mosaic virus carrying a modified bacterial methotrexate-resistance gene was used to infect a plant, whereby the foreign gene was systemically spread in the plant.
  • Exogenous DNA can be introduced into cells or protoplasts by microinjection.
  • Microinjection is a method where a solution of plasmid DNA is injected directly into the cell with a finely pulled glass needle. Alfalfa protoplasts have been transformed utilizing this method with a variety of plasmids. Reich, T.J. et al., Bio/Technology 4:1001 (1986).
  • liposome fusion protoplasts and liposomees carrying the foreign gene of interest are brought together. As membranes merge, the foreign gene is transferred to the protoplast.
  • Deshayes, A. et al. "Liposome-Mediated Transformation of Tobacco Mesophyl Protoplasts by an Escherichia coli Plasmid," EMBO J. 4:2731 (1985).
  • a form of chemical mediated transformation utilizes polyethylene glycol (PEG) and has been carried out in N. tabacum a dicot, and Lolium multiflorum, a monocot. It is a chemical procedure of direct gene transfer based on synergistic interaction between Mg 2+ , PEG, and possibly Ca 2+ . ⁇ egrutiu, R. et al., Plant Mol. Biol.. 8:363 (1987).
  • plants can be regenerated from tissue transformed with A. tumefaciens.
  • tissue transformed with A. tumefaciens include sunflower, Everatt, ⁇ .P. et al., supra; tomato, Fillatti, J.J. et al., supra; white clover, White, D.W. R. et al., Plant Mol. biol. 8:461 (1987); canola (rapeseed), Pua, E-C, et al., supra; cotton, Umbeck, P. et al., supra; tobacco, Horsch, R.B. et al., Science 225:1229 (1985) and Hererra- Estrella, L. et al., Nature.
  • Plant regeneration from protoplasts is a particularly useful technique. See Evans, D.A. et al., Handbook of Plant Cell Culture. 1:124 (1983). When a plant species can be regenerated from protoplasts, then direct gene transfer procedures can be utilized, and transformation is not dependent on the use of A. tumefaciens. Regeneration of plants from protoplasts has been demonstrated for rice, Abdullah, R. et al., Bio/Technology 4:1087 (1987); tobacco, Potrykus, I. et al., supra; canola, Kansha, et al., Plant Cell Reports 5:101 (1986); potato, Tavazza, R. et al., Plant Cell Reports 5:243 (1986); eggplant, Sihackaki, D.
  • the organohydrolase may be harvested from the plant or the plant itself may be used to detoxify sites contaminated by organophosphorous neurotoxins, from insecticides, pesticides or even for use in chemical warfare detoxification.
  • the expression cassette After the expression cassette is stably incorporated into regenerated transgenic plants, it can be transferred to other plants by sexual crossing. Any of a number of standard breeding techniques can be used, depending upon the species to be crossed.
  • plants may be self-fertilized, leading to the production of a mixture of seed that consists of, in the simplest case, three types, homozygous (25%), heterozygous (50%) and null (25%) for the inserted gene.
  • homozygous 25%
  • heterozygous 50%)
  • null 25%)
  • Transgenic homozygous parental lines make possible the production of hybrid plants and seeds which will contain a modified protein component.
  • Transgenic homozygous parental lines are maintained with each parent containing either the first or second recombinant DNA sequence operably linked to a promoter. Also incorporated in this scheme are the advantages of growing a hybrid crop, including the combining of more valuable traits and hybrid vigor.
  • an OPH gene was created. This was accomplished by analyzing the amino acid sequence of OPH using the program BACKTRANSLATE (Wisconsin package version 9.1, Genetics Computer Group(GCG), Madison, Wisconsin) into a DNA coding sequence using a maize codon preference table tabulated from highly expressed maize genes (http://www.gcg.com/techsupport/data/maize-high.cod). The optimized sequence was then searched for putative deleterious sequences compiled in Table 1 using the GCG program FINDPATTERNS.
  • Alternative codons were chosen to eliminate the deleterious mRNA signals in the DNA coding sequence and to add convenient restriction enzyme sites to facilitate downstream cloning. Codons that reflected less than 20% usage were avoided.
  • the optimized DNA coding sequence was divided into a convenient cloning length of less than 350 base pairs.
  • Each of the fragments was divided up into oligonucleotides of approximately 50 bases in length with 10 base overhangs. Oligonucleotides corresponding to both the sense and antisense strand were synthesized using a commercial supplier and all oligonucleotides were 5' phosphorylated. The oligonucleotides were diluted to 100 pmol/ ⁇ l and 1 nanomole of each oligonucleotide in each respective fragment was added to a microfuge tube and brought to 100 ⁇ l using water. The oligonucleotides were annealed by heating to 95°C and allowed to cool slowly to 4°C over a period of two hours.
  • oligonucleotides were ligated at 16°C for one hour. Following the ligation, 1 ⁇ l and successive 1/10 dilutions were subjected to PCR using primers specific to the 5' and 3' ends of each fragment. The PCR reactions were then purified by polyacrylimide gel electrophoresis. The band corresponding to the correct size of each fragment was excised, and the DNA eluted from the gel slice using proceduresknown to those of skill in the art.
  • the eluted DNA was cloned into the pCR2.1-TOPO (Invitrogen) as per the manufacturer's directions. Colonies containing the PCR insert were grown overnight, the plasmid DNA extracted and purified, and the plasmid DNA analyzed for the correct PCR insert as per standard protocols to those known of skill in the art. The inserts were sequenced to verify the correct sequence of each fragment and then the optimized gene was assembled (SEQ ID NO:l) using standard protocols known to those of skill in the art. The 5' fragment was assembled to contain a plant leader sequence (SEQ ID NO:2) to ensure high expression in plants and the OPH gene containing the plant leader (SEQ ID NO: 3) was cloned into a standard plant expression cassette to ensure high expression in plants.
  • SEQ ID NO:2 plant leader sequence
  • SEQ ID NO:3 was cloned into a standard plant expression cassette to ensure high expression in plants.
  • Linearized or supercoiled plant vector DNA containing the OPH gene and plant leader sequence is mixed with the protoplasts in a final volume of 0.5 ml at a concentration of 0.1 mg/ml and 7 x 10 5 cells/ml respectively in a 16 mm diameter Nunc Multidish well.
  • a single pulse is administered at room temperature (23°C) in a Hoefer PG 101 ProGenetor electroporation unit using a PG120-2.5 electrode for 10 msec at 200 V. Electroporated protoplasts are kept stationary for 10 minutes prior to the addition of 1 ml of culture medium. Cells were subsequently diluted to a final concentration of 10 5 cells/ml. These cells may then be assayed for transient expression of the OPH gene after a period of 40-48 hours or depending on the DNA vector construct used, plated to generate callus tissues under appropriate selection, followed by regeneration to whole plants.
  • Regen I promotes somatic embryo differentiation (See Abbe & Stein, "The Origin of the Shoot Apex in Maize; Embryogeny", N.J. Bot. 41:285, 293 (1954)).
  • Regen II promotes embryo enlargement and maturation, and Regen III promotes germination.
  • the tissue is incubated on each medium for approximately two weeks. The first two incubation steps are carried out in the dark at 28°C and the final incubation step is carried out under a 16:8-hour photo period with about 70 ⁇ E ⁇ r 2 sec 1 provided by cool-white fluorescent bulbs at about 25°C.
  • the plates Upon completion of all three incubations, the plates are placed in a single layer on shelves in a lighted incubator and are sealed with 3-M Scotch Brand #394 mending tape.
  • 3-M tape is preferred over either Parafilm or masking tape as it "breathes" better and helps reduce condensation problems.
  • Small green shoots formed on Regen III in 100 x 25-mm petri plates are transferred to Regen III medium and 200 x 25- mm Pyrex tubes or Phytatrays to permit further plantlet development and root formation.
  • the plants may be carefully removed from the medium, the root system washed thoroughly under running water, and the plants placed into a 2. 5" square pot containing Metromix 350 growing medium. Watering with the systemic fungicide benomyl (100 mg/1 Benlate) will reduce the risk of fungal contamination. It is critical to maintain the freshly transplanted plants in a high humidity environment for several days.
  • Regeneration of plants from Type II callus is based upon allowing the embryoids on the surface of the Type II callus to mature and germinate. See Freeling & Walbot, The Maize Handbook (1994) at page 673-674. The procedure used is essentially that as described in Freeling & Walbot. The callus are first collected and weighed in petri plates. 1-2 grams fresh weight of soft, friable Type II callus containing numerous embryoids are evenly distributed over the surface of a 100 x 15-mm petri plate which contains 25 ml of regeneration medium.
  • Regeneration medium consists of Murashige and Skoog (MS) basal salts, modified White's vitamins (0.2 g/1 glycine, and 0.5 g/1 of each of thiamine-HCl, pyridoxine-HCl, and nicotinic acid), supplemented with 6% sucrose, 0.1 g/1 myo-inositol, and 0.8% Bacto-ager (6SMS0D).
  • MS Murashige and Skoog
  • modified White's vitamins 0.2 g/1 glycine, and 0.5 g/1 of each of thiamine-HCl, pyridoxine-HCl, and nicotinic acid
  • 6SMS0D Bacto-ager
  • the plate should be examined for shoot formation from the calli.
  • the calli and the shoot should then be transferred to fresh Bacto-ager plates for another two weeks.
  • the callus without shoots can be left on the Bacto-ager for a longer period if the callus is slow in embryo development.
  • Magenta GA-7 Magneticenta Corp., Chicago, IL
  • Organophosphorous hydrolase that is produced by transformed maize plants containing the optimized OPH gene and plant leader sequence is purified by standard methods known to those in the art.
  • the presence of the OPH protein can be detected utilizing protein purified from transformed plant tissues.
  • the expression and stability of the OPH gene product can be assayed by allowing the OPH optimized gene product to come into association with the pesticide, neurotoxin, or compound containing phosphoryl-bonds. These compounds can then be analyzed to determine if the OPH gene product hydrolyzed the P-O, P-F, P-CN, and/or P-S phosphoryl-bonds.

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)

Abstract

L'invention porte sur: une séquence de nucléotides optimisée en vue de l'expression de plantes et codant pour des hydrolases organophosphorées. L'invention porte également sur des produits d'assemblage d'expression, sur des vecteurs de transformation et sur des cellules transformées atteignant des niveaux d'expression supérieurs à ceux obtenus par expression dans des bactéries telles que le E. Coli en vue de la production à fort rendement de l'enzyme. On peut utiliser les plantes transgéniques elles-mêmes ou récolter la protéine dans lesdites plantes pour la détoxication in situ ou autre de l'environnement dans des zones contaminées par des neurotoxines organophosphorées.
PCT/US1999/008202 1998-04-15 1999-04-14 Sequences optimisees de nucleosides codant pour des hydrolases organophosphorees, et leurs methodes d'utilisation WO1999053037A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU40689/99A AU4068999A (en) 1998-04-15 1999-04-14 Optimized nucleotide sequence encoding organophosphorous hydrolase and methods of use for same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8184698P 1998-04-15 1998-04-15
US60/081,846 1998-04-15

Publications (2)

Publication Number Publication Date
WO1999053037A2 true WO1999053037A2 (fr) 1999-10-21
WO1999053037A3 WO1999053037A3 (fr) 1999-12-09

Family

ID=22166780

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/008202 WO1999053037A2 (fr) 1998-04-15 1999-04-14 Sequences optimisees de nucleosides codant pour des hydrolases organophosphorees, et leurs methodes d'utilisation

Country Status (2)

Country Link
AU (1) AU4068999A (fr)
WO (1) WO1999053037A2 (fr)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001071014A2 (fr) * 2000-03-17 2001-09-27 Boyce Thompson Institute For Plant Research, Inc. Expression d'acetylcholinesterase de recombinaison humaine dans des plantes transgeniques
WO2002092803A1 (fr) * 2001-05-15 2002-11-21 Commonwealth Scientific And Industrial Research Organisation Phosphotriesterase issue d'agrobacterium radiobacter p230
US7060501B2 (en) * 2002-12-03 2006-06-13 Applied Biotechnology Institute Methods for selecting and screening for plant cells transformed with a polynucleotide encoding an organophosphate hydrolase
GB2430436A (en) * 2002-09-09 2007-03-28 C Steven Mcdaniel Biological active coating components
CN1330760C (zh) * 2005-10-11 2007-08-08 中国农业科学院生物技术研究所 重组有机磷降解酶基因、其表达载体及重组有机磷降解酶的制备方法
CN102145218A (zh) * 2010-11-24 2011-08-10 高旌 一种植物体中农药快速降解剂
EP2441834A1 (fr) * 2007-10-01 2012-04-18 Guild Associates, Inc. Biocapteurs de levure différentiellement fluorescente pour la détection et la biodégradation d'agents chimiques
US8388904B1 (en) 2008-12-22 2013-03-05 Reactive Surfaces, Ltd., Llp Equipment decontamination system and method
US9796990B2 (en) 2011-07-20 2017-10-24 Commonwealth Scientific And Industrial Research Organization Enzymes for degrading organophosphates

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990002177A1 (fr) * 1988-08-26 1990-03-08 Amgen Inc. Analogues d'hydrolase de parathion et procedes de production et de purification
EP0682115A1 (fr) * 1988-09-09 1995-11-15 Mycogen Plant Science, Inc. Gène synthétique pour une protéine-cristal insecticide
US5474925A (en) * 1991-12-19 1995-12-12 Agracetus, Inc. Immobilized proteins in cotton fiber

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990002177A1 (fr) * 1988-08-26 1990-03-08 Amgen Inc. Analogues d'hydrolase de parathion et procedes de production et de purification
EP0682115A1 (fr) * 1988-09-09 1995-11-15 Mycogen Plant Science, Inc. Gène synthétique pour une protéine-cristal insecticide
US5474925A (en) * 1991-12-19 1995-12-12 Agracetus, Inc. Immobilized proteins in cotton fiber

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CUNNINGHAM S D ET AL: "PROMISES AND PROSPECTS OF PHYTOREMEDIATION" PLANT PHYSIOLOGY, vol. 110, 1 January 1996 (1996-01-01), pages 715-719, XP002051868 ISSN: 0032-0889 *
SALT D E ET AL: "PHYTOREMEDIATION: A NOVEL STRATEGY FOR THE REMOVAL OF TOXIC METALS FROM THE ENVIRONMENT USING PLANTS" BIO/TECHNOLOGY, vol. 13, no. 5, 1 May 1995 (1995-05-01), pages 468-474, XP000577130 ISSN: 0733-222X *
XU B ET AL.: "Enhanced Expression of a Bacterial Gene for Pesticide Degradation in a Common Soil Fungus" JOURNAL OF FERMENTATION AND BIOENGINEERING, vol. 81, no. 6, 1996, pages 473-481, XP002112416 *

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001071014A2 (fr) * 2000-03-17 2001-09-27 Boyce Thompson Institute For Plant Research, Inc. Expression d'acetylcholinesterase de recombinaison humaine dans des plantes transgeniques
WO2001071014A3 (fr) * 2000-03-17 2002-05-30 Thompson Boyce Plant Res Expression d'acetylcholinesterase de recombinaison humaine dans des plantes transgeniques
US8557547B2 (en) 2001-05-15 2013-10-15 Commonwealth Scientific And Industrial Research Organisation Phosphotriesterase from agrobacterium radiobacter P230
US8293244B2 (en) 2001-05-15 2012-10-23 Commonwealth Scientific And Industrial Research Organisation Phosphotriesterase from agrobacterium radiobacter p230
AU2002252842B2 (en) * 2001-05-15 2006-08-31 Commonwealth Scientific And Industrial Research Organisation Phosphotriesterase from Agrobacterium radiobacter P230
WO2002092803A1 (fr) * 2001-05-15 2002-11-21 Commonwealth Scientific And Industrial Research Organisation Phosphotriesterase issue d'agrobacterium radiobacter p230
GB2430436B (en) * 2002-09-09 2007-06-06 C Steven Mcdaniel Biological active coating components, coatings, and coated surfaces
GB2430436A (en) * 2002-09-09 2007-03-28 C Steven Mcdaniel Biological active coating components
US10413769B2 (en) 2002-09-09 2019-09-17 Reactive Surfaces, Ltd., Llp Paint having cell wall particulate material with a protective organophosphorus esterase
US7060501B2 (en) * 2002-12-03 2006-06-13 Applied Biotechnology Institute Methods for selecting and screening for plant cells transformed with a polynucleotide encoding an organophosphate hydrolase
CN1330760C (zh) * 2005-10-11 2007-08-08 中国农业科学院生物技术研究所 重组有机磷降解酶基因、其表达载体及重组有机磷降解酶的制备方法
EP2441834A1 (fr) * 2007-10-01 2012-04-18 Guild Associates, Inc. Biocapteurs de levure différentiellement fluorescente pour la détection et la biodégradation d'agents chimiques
US8927244B2 (en) 2007-10-01 2015-01-06 Guild Associates, Inc. Organophosphorus hydrolase
US8388904B1 (en) 2008-12-22 2013-03-05 Reactive Surfaces, Ltd., Llp Equipment decontamination system and method
CN102145218A (zh) * 2010-11-24 2011-08-10 高旌 一种植物体中农药快速降解剂
US9796990B2 (en) 2011-07-20 2017-10-24 Commonwealth Scientific And Industrial Research Organization Enzymes for degrading organophosphates

Also Published As

Publication number Publication date
AU4068999A (en) 1999-11-01
WO1999053037A3 (fr) 1999-12-09

Similar Documents

Publication Publication Date Title
Mader et al. Three amino acids of the oestrogen receptor are essential to its ability to distinguish an oestrogen from a glucocorticoid-responsive element
Uwer et al. Inactivation of a glycyl-tRNA synthetase leads to an arrest in plant embryo development
CA2106718C (fr) Methodes d'obtention de semence hybride
KR100278819B1 (ko) 형질전환식물에서웅성불임성을위한가역적핵유전시스템
AU718262B2 (en) Methods and constructs for producing male sterile plants
CN102821598A (zh) 供植物中基因靶向用的工程化降落场
AU7107198A (en) An oleosin 5' regulatory region for the modification of plant seed lipid composition
CN111433363B (zh) 非生物胁迫耐性提高的植物和提高植物非生物胁迫耐性的多聚核苷酸及方法
Charity et al. Consistent and stable expression of the npt II, uid A and bar genes in transgenic Pinus radiata after Agrobacterium tumefaciens-mediated transformation using nurse cultures
JP2002532114A (ja) トランスジェニック植物およびその作出法
US6603064B1 (en) Nuclear male sterile plants, method of producing same and methods to restore fertility
WO1999053037A2 (fr) Sequences optimisees de nucleosides codant pour des hydrolases organophosphorees, et leurs methodes d'utilisation
CN105061569A (zh) 一种与植物抗逆性相关的SiMYB107蛋白及其相关生物材料与应用
JP4603882B2 (ja) 子孫への形質分配が制御されているトランスジェニック植物
CN117587059A (zh) 调控植物中基因表达的启动子
US20060294619A1 (en) Method for plant transformation based on thje pollination-fecundation pathway and the products thereof
EP4426819A1 (fr) Adn polymérase sujette aux erreurs pour mutation d'organites
CN113215186B (zh) 光呼吸支路蛋白在调控植物性状中的应用
JPH08506003A (ja) クルーシファaccシンターゼおよびその利用
US20080235824A1 (en) Use of Esterase Genes as Selectable Markers for Transforming Plant Cells
WO2021016906A1 (fr) Plantes tolérantes au stress abiotique et procédés
US20030018995A1 (en) Plants with a modified flower and seed development
US7557265B2 (en) Plant phytase genes and methods of use
CA2200496C (fr) Transformation genetique a l'aide d'un inhibiteur de la parp
CA3205117A1 (fr) Procedes et compositions pour plants de petite taille par manipulation du metabolisme de la gibberelline

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase in:

Ref country code: KR

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase